Committees
Bylaw Committee
The Bylaw Committee is responsible for the creation and maintenance of the organization's bylaws, which is the set of rules that guide its operations and activities. Duties include:
- Review proposed amendments and recommend for board consideration changes to the bylaws that are consistent with the Association's overall mission and purpose.
- In response to requests from the board and/or president, review and make recommendations for changes to the bylaws.
- Examine and consider the implications of proposed changes and make recommendations to the board.
- Ensure adherence to the bylaw amendments process and timeline.
Committee Members Include: Oscar Signori, M.D., FACP; Mohammad Ogaily, M.D., FACP; Anas Al-Janadi, M.D.; Jerome Winegarden, M.D.
Contractor Advisory Committee
The primary function of the Contractor Advisory Committee (CAC) is to provide feedback to WPS GHA on Local Coverage Determinations (LCD) while in the draft process from the medical professionals practicing in the jurisdiction.
CAC Members Commitment
- Provide specialty expertise to WPS GHA Policy staff as requested
- Gather feedback on draft policies from other professionals and societies regarding LCDs
- Attend the CAC meeting or contact the alternate
- Provide LCD feedback to WPS GHA policy staff
- Provide Medicare literature to WPS GHA Policy staff in writing
- Receive current Medicare updates and share with others in the medical field
Committee Members Include: Anas Al-Janadi, M.D., Hematology Representative; Sree Chandana, M.D., Oncology Representative; Ammar Sukari, M.D., Oncology Alternate
Education Committee
MSHO’s commitment to providing our members and their staff relevant, unbiased information on recent advances that contribute to the care of their patients is the charge of the education committee. Responsibilities for Education Committee members are:
- To see that MSHO continues to meet the educational needs of our members
- To participate in planning committees and course director positions for the delivery of MSHO educational programs
- To monitor and assess accreditation, corporate funding, Society resources, and other issues involved in the development and delivery of MSHO educational programming
- To oversee new program development
- To facilitate discussions about program priorities for the Society
Committee Members Include: Dan Isaac, D.O.; Oscar Signori, M.D., FACP; Ulka Vaishampayan, M.D.; Philip Philip, M.D., Ph.D., FRCP
Fellow Representative: Nathaniel Wilson, M.D.
Executive Committee
The Executive Committee is responsible for the general affairs of the MSHO Board of Directors and has the following responsibilities:
- To prioritize the activities of the Board in alignment with the Society’s strategic plan
- To recruit Society committee leadership from within the Board of Directors
- To meet with prospective Board members and recommend candidates to the Board
- To conduct orientation sessions for new Board members
- To develop and apply guidelines for ensuring ethical behavior and resolving ethical conflicts
- To assure the Board regularly engages in self-assessment
- To assure the Board regularly engages in strategic planning
Committee Members Include: Philip Kuriakose, M.D., FACP; Jerome Winegarden, M.D.; Dan Isaac, D.O.; Michael Stender, M.D., FACP; Mary Kay Makarewicz
Membership Committee
The Membership Committee is charged with monitoring current MSHO member satisfaction, participation and investigating new membership opportunities to reflect the delivery of hematology and oncology care in Michigan. The tasks of this committee are:
- Track membership recruitment and retention
- Consider expansion options for membership for specialists and affiliated healthcare professionals who are aligned with the goals and mission of MSHO
- Consider updated membership categories based on the site of care delivery
- Determine dues structure and corresponding benefits for MSHO membership
Committee Members Include: JoAnn Hirth, M.D.; Carol Rapson, M.D.; Edward Smith, M.D.; Timothy Cox, M.D.; Ulka Vaishampayan, M.D.; Mohammad Ogaily, M.D. FACP; Anas Al-Janadi, M.D.; Mohammad Omaira, M.D.; Shruti Jolly, M.D.
Payer Advisory Committee
The Payer Advisory Committee responds to requests from both MSHO members and payers (Medicare, Medicaid, and private payers) regarding coverage for oncology and hematology treatment. The committee’s role is to support access to the appropriate and timely treatment through policy review, clinical evidence intervention. The duties of the Payer Advisory Committee are:
- To provide a timely response to coverage inquiries
- To review scientific data from defined sources regarding appropriate coverage of drugs used in cancer treatment
- To investigate inquiries regarding prior authorizations, step therapy and other payer-initiated utilization restrictions
- To participate in meetings and discussions with payer medical directors
- To attend at least one CAC WPS meeting per year – CAC Rep only
- To attend annual ASCO/ASH CAC Meeting (DC) – CAC Reps alternate
Committee Members Include: Anas Al-Janadi, M.D.; Thomas Gribbin, M.D.; Michael Stender, M.D., FACP; Andrew Muskovitz, M.D.; Philip Kuriakose, M.D.; Sree Chandana, M.D.; Ammar Sukari, M.D.
Fellow Representative: Ritesh Patel, M.D.
Public Policy Committee
MSHO’s Public Policy Committee Counsels the Board of Directors of actions that should be taken to defend, support or challenge decisions that impact the care of cancer patients. The members of this committee:
- Stay informed on relevant state and national legislative, executive and judicial issues by reviewing bill tracking and other reports from MSHO’s contracted Government Affairs Consultant and national and local organizations (ASCO, ASH, ACCC, COA, MCC,etc)
- Bring proposals to the table for a board position or MSHO intervention
- Work with appropriate staff to draft policy positions to share with MSHO members, elected officials, media when appropriate
- Evaluates the value of MSHO’s Government Affairs Consultant position and makes recommendations for contracting this position
- Provide or solicit testimony for important policy hearings
Committee Members Include: Jerome Seid, M.D., FACP; Timothy Cox, M.D., FACP; Yelena Kier, D.O., FACOI; Daniel Isaac, D.O.; Zachary Hector-Word, M.D.;Philip Philip, M.D., Ph.D., FRCP
Research Committee
The Research Committee is dedicated to expanding and strengthening the research pillar of our society. This group explores opportunities to support, promote, and engage in research that advances patient care, informs policy, and enhances professional education. By assessing current gaps, identifying potential partnerships, and developing initiatives, the committee aims to position our organization as a key facilitator of impactful research in our field.
Committee Members Include: Daniel Isaac, D.O.; Andrew Muskovitz, M.D.; Rupin Shah, M.D.; Shruti Jolly, M.D.; Philip Philip, M.D., Ph.D., FRCP; Ammar Sukari, M.D.; Ulka Vaishampayan, M.D.
Young Professional Committee
The work of the Young Professional Committee is to educate and mentor young physicians and fellows to support their interest in hematology and oncology. The tasks of this committee are:
- To provide clinical education to support young physicians’ pursuit of Board Certification
- To provide an awareness of practical career development considerations
- To provide a source of Michigan employment opportunities for young physicians
- To provide peer networking opportunities and resources
- To expose young physicians to the value of participating in organizations such as MSHO to further their specialty
- To work with Fellowship Program Directors to allow fellows to participate in MSHO initiatives
Committee Members Include: Anas Al-Janadi, M.D.; JoAnn Hirth, M.D.; Hirva Mamdani, M.D.; Oscar Signori, M.D. FACP; Mohammad Ogaily, M.D., FACP; Ulka Vaishampayan, M.D., Mohammad Omaira, M.D.; Ammar Sukari, M.D.; Jerome Winegarden, M.D.; Markie Zimmer, M.D.; MacKenzie Mayo, M.D.
About
Advocacy
MSHO continuously contacts legislators, provides comments to policy makers, and collaborates with payers on issues of concern to those delivering care to cancer patients.
more informationEducation
It is important that our members are aware of meetings, webinars, and other educational opportunities specifically designed to address the complexities of cancer care.
more informationResearch
MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.
more informationReport Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
Report Broken Link
